08 January,2021 06:11 PM IST | London | IANS
Nurse Laura Bailey draws the Moderna vaccine from the first batch of Moderna`s vaccine at Hartford hospital in Hartford, Connecticut on December 21, 2020. Pic/AFP
The UK's regulatory authority on Friday approved a third COVID-19 vaccine for use in the country, made by the company Moderna.
However, supplies of the new jab are not expected to be available until the spring in a few weeks' time as the UK has pre-ordered 7 million doses. In trials with more than 30,000, the Moderna vaccine offered nearly 95 per cent protection from severe COVID.
The Moderna vaccine works in a similar way to the Pfizer/BioNTech vaccine that is already being offered by the National Health Service (NHS). It requires temperatures of around -20C for shipping -- similar to a normal freezer. In comparison, the Pfizer/BioNTech one requires temperatures closer to -75C, making transport logistics much more difficult.
The Oxford/AstraZeneca jab is easier to store and distribute, as it can be kept at normal fridge temperature.
All three vaccines, now cleared for use in the UK, require a second booster shot.
Around 1.5 million people in the UK have had at least one dose of COVID-19 vaccine so far, the Pfizer/BioNTech and Oxford/AstraZeneca jabs.
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever